Latest Europe News

Zoono Group Limited has responded to an ASX price query following a recent surge in its share price and trading volume, confirming no undisclosed information exists and attributing market activity to ongoing shelf-life extension trials across multiple continents.

European Lithium has offloaded an additional US$50 million worth of Critical Metals Corp shares, coinciding with CRML’s own US$50 million capital raise to advance its Greenland rare earth project.

Talga Group has won a SEK 82.6 million (A$13.3 million) grant from the Swedish Energy Agency to advance its low-emission graphite anode project, accelerating its path to commercial-scale production in Sweden.

Vulcan Energy has awarded a €140 million contract to JordProxa for critical lithium purification and processing technology at its Phase One Lionheart Project in Germany, marking a pivotal step towards Europe’s first sustainable lithium supply chain.

PainChek Limited has appointed Sasha Grant as Head of Growth for its AI-powered Infant App, aiming to scale its presence in a $15 billion global market. Early Australian adoption shows promising conversion rates as the company prepares for international expansion.

IMDEX Limited reported a resilient FY25 with steady margins, reduced net debt, and strategic acquisitions positioning it for growth. The company’s FY26 outlook is optimistic, supported by improving global exploration activity and technology adoption.

Health Canada has requested additional information, extending its review of CLINUVEL’s SCENESSE® for erythropoietic protoporphyria (EPP) into 2026. Meanwhile, Canadian patients continue to access the treatment via a Special Access Program.

Anteris Technologies has secured its first European regulatory clearance to commence the global PARADIGM Trial for its DurAVR Transcatheter Heart Valve, marking a significant step toward worldwide commercialization.

TrivarX Limited has announced the acquisition of Stabl-Im, a novel stable isotope MRI technology for early brain tumor detection, backed by a $4.2 million capital raise including investment from biotech leader Dr Daniel Tillett.

Biotron Limited is set to acquire Sedarex Limited, gaining global patents for SedRx, a next-generation general anaesthetic, supported by a $2.5 million capital raising to fund regulatory and development milestones.

Compumedics has secured a $2.15 million placement to fast-track commercialisation of its Somfit D device following early FDA approval, positioning the company for significant growth in the US home sleep testing market.

DroneShield has launched DroneSentry-C2 Enterprise, a SaaS platform designed for national-scale counter-drone command, with its first paid deployment set for early 2026 on the Eastern NATO flank.